Grc 4039
Interact & exchange stock tips & market info »
Related News »
Glenmark Pharmaceuticals' molecule, GRC 4039, for treating rheumatoid arthritis, inflammation and multiple sclerosis (a form of blood cancer), has entered the first phase of human clinical trials Glenmark outlicences drug for $350 mn to Eli 31-OCT-07 ...
May 24, 2012 at 19:32 | Source: Business Standard






